ATLAS-OLE: An Open-label, Long-term Safety and Efficacy Study of Fitusiran in Patients with Hemophilia A or B, with or without Inhibitory Antibodies to Factor VIII or IX.
- Tran, Huyen (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research